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Plectin Serves as an Autoantigen in Paraneoplastic Pemphigus
To the Editor:
Paraneoplastic pemphigus (PNP) is an autoimmune disease associated
with malignant lymphoproliferative disorders, manifesting with
extensive blistering of the skin and erosions of the oral mucosal
membranes (Anhalt et al, 1990; Anhalt, 1997). We have previously
shown by immunoblot analysis that PNP autoantibodies recognize
various plakin proteins, including plectin, a high-molecular weight,
ubiquitously expressed adhesion molecule (Mahoney et al, 1998).
Quite recently, plectin has been shown to be recognized by PNP sera
using a combination of immunoprecipitation and western blotting
techniques (Proby et al, 1999). In this study, we have utilized affinity
purified autoantibodies to demonstrate that, in addition to other
plakins, plectin definitively serves as an autoantigen in PNP. Further-
more, our data suggest that the conserved carboxy-terminal region
of these plakin proteins functions as a common antigenic epitope
recognized by autoantibodies in PNP.
In the first set of experiments, we used glutathione-S-transferase
(GST) fusion proteins corresponding to the linker region of five
members of the plakin family of proteins, including BPAG1, desmo-
plakin, envoplakin, periplakin, and plectin (PL). Antibodies from
two previously characterized PNP sera, PNP3023 and PNP3021,
were affinity purified using PL-GST fusion protein. The affinity
purified antibodies were then concentrated and tested in western
analysis. The antibodies from both PNP sera purified with PL-GST
recognized, in addition to plectin, epitopes in periplakin, envoplakin,
and desmoplakin fusion proteins. Interestingly, the reaction with
envoplakin was the strongest, possibly reflecting the presence of
multiple antigenic sites and/or higher affinity for a single epitope
within this molecule (Fig 1A, panels 1 and 2). Exogenously added
PL-GST (1 µg per ml) was able to compete off the binding to all
proteins (data not shown). Thus, the PNP antibodies specific to
certain protein epitopes also recognize other members of the plakin
family, suggesting the presence of shared epitopes.
Secondly, immunoprecipitations of radio-labeled proteins in ker-
atinocyte extracts with two PNP sera were performed (Fig 1B). As
expected, the original, unfractionated PNP serum 3023 precipitated
characteristic bands of 250, 230, 210, 190, and 170 kDa (Fig 1B, lane
2). In addition, at least two closely migrating bands, .250 kDa, were
noted. The PNP serum 3021 immunoprecipitated clearly detectable
bands of 230, 190, and 170 kDa, whereas bands of 250 and 210 kDa
were barely detectable (Fig1B, lane 3). Immunoprecipitation analysis
using antibodies from PNP sera 3023 and 3021, which were affinity
purified with PL-GST fusion protein, revealed precipitation of mul-
tiple bands similar to those seen in the original precipitations with
PNP serum. Interestingly, immunoprecipitates with affinity purified
antibodies did not include the 170 kDa band suggesting that this
protein does not share epitopes with the plakin proteins, but instead,
the PNP sera may contain antibodies specifically recognizing the
170 kDa protein. The nature of the 170 kDa protein is currently
unknown, but it is clearly larger than desmoglein 3, which also has
been shown to be recognized by PNP sera (Amagai et al, 1998).
Furthermore, immunoprecipitation with antibodies purified with
PL-GST fusion protein also recognized, although weakly, one of the
high molecular weight bands, .400 kDa, further suggesting the
presence of plectin.
The monoclonal antibody AE11 has been previously reported to
recognize a 195 kDa protein by immunoblotting in human epidermal
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keratinocytes (Ma and Sun, 1986), which may be periplakin based
on its approximate size. To test this possibility, we used the GST
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Figure 2. The antigenic profile for plakin protein linker domains. Each profile was generated using MacVector 6.0 program (Oxford Molecular,
Campbell, CA). The corresponding amino acid sequences are shown above each antigenic profile. PP, periplakin; EV, envoplakin; DP, desmoplakin; PL,
plectin; BPAG1, bullous pemphigoid antigen 1.
fusion proteins to test the specificity of the AE11 antibody. This
monoclonal antibody recognized not only the periplakin fusion pro-
tein but also, with somewhat lower intensity, envoplakin, plectin,
desmoplakin, and BPAG1 fusion proteins (Fig 1C). These data fur-
ther emphasize the presence of shared epitopes in plakin proteins.
Finally, because the primary amino acid sequence of the linker
region of all five plakin proteins is known, we examined the potential
of these peptide segments to serve as autoantigens. For this reason,
each linker domain was first subjected to the computer prediction
for antigenic index, based on the hydrophilicity, surface probability,
and flexibility of the protein, as predicted from the primary sequence
(Fig 2). Several segments with high antigenic potential were identi-
fied in all proteins, and many of them were shared between two
or more. In particular, a region with positive antigenic index was
recognized in all sequences surrounding the amino acid 71 (Fig 2).
Furthermore, the region around amino acid 20 and that spanning
amino acids 57–62 showed a positive index in four of five proteins.
It was of interest to note that envoplakin had a region, between
amino acids 20–40, which showed several peaks of high antigenic
potential, whereas the corresponding region in other plakin proteins
appeared less antigenic.
Figure 1. PL-GST antibodies affinity purified from PNP sera and
a monoclonal antibody AE11 recognize plakin tail-GST fusion
proteins. (A) Western blot analysis of recombinant GST and GST-fusion
proteins composed of the conserved region within the tail domains of
periplakin (PP), envoplakin (EV), plectin (PL), and desmoplakin (DP)
(1 µg per lane) with PNP3023 PL-GST purified antibodies (panel 1) and
PNP3021 PL-GST purified antibodies (panel 2). Preparation of the fusion
proteins has been described elsewhere (Mahoney et al, 1998). (B)
Metabolically labeled keratinocyte cell lysate was subjected to
immunoprecipitation by normal human serum (NHS), PNP3023 serum,
PNP3021 serum, PL-GST affinity purified antibodies from PNP3023, and
PL-GST affinity purified antibodies from PNP3021, as described previously
(Mahoney et al, 1998). (C) Western blot analysis of plakin-GST proteins
(20 ng per lane in panel 1, and 400 ng per lane in panel 2) with anti-GST
antibody (panel 1) and the monoclonal antibody AE11 (panel 2).
In summary, our data confirm that plectin is an autoantigen in PNP,
and collectively, these findings contribute to better understanding of
the pathogenesis of PNP.
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